Аннотация
Психические расстройства у лиц старше 18 лет достаточно распространены и представлены довольно обширным списком заболеваний. У пациентов с подобной патологией также возникает необходимость проведения вмешательств и манипуляций в условиях анестезии. В статье представлены принципы ведения периоперационного периода у больных с наиболее распространенными психическими заболеваниями — аффективные расстройства, шизофрения, биполярное расстройство, тревожные расстройства, поведенческие синдромы, связанные с физиологическими нарушениями (булимия, анорексия). Отражены профилактика рецидивов психического заболевания и синдрома отмены, профилактика инцидентов, связанных с приемом препаратов, применяемых для терапии психопатологии.Библиографические ссылки
- Беккер Р.А., Быков Ю.В. Проблематика проведения общей анестезии на фоне приема психофармакотерапии (Часть I). Портал Consilium Medicum: https://con-med.ru/upload/iblock/eee/psi-for-site-bykov1.pdf. Доступ к статье проверен 25.02.2020. [Becker R.A., Bykov S.E. Problems of conducting general anesthesia while taking psychopharmacotherapy (Part I). Portal Consilium Medicum: https://con-med.ru/upload/iblock/eee/psi-for-site-bykov1.pdf (In Russ)]
- Levenson J.L. Psychiatric issues in surgical patients. Part I. General issues, Prim Psychiatry. 2007; 14: 35–39.
- Practice Advisory for Preanesthesia Evaluation: An Updated Report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation Anesthesiology. 2012; 3(116): 522–538. (https://anesthesiology.pubs.asahq.org/article.aspx?articleid=2443414). DOI: https://doi.org/10.1097/ALN.0b013e31823c1067
- Hemmings H.C., Hopkins P.M. Foundations of anesthesia: basic sciences for clinical practice. 2nd ed. Elsevier Health Sciences; 2006: 346–347.
- Attri J., Bala N., Chatrath V. Psychiatric patient and anaesthesia. Indian Journal of Anaesthesia. 2012; 56(1): 8–13. DOI: 10.4103/0019-5049.93337
- Kessler R.C., Berglund P., Demler O., et al. The Epidemiology of Major Depressive Disorder. JAMA. 2003; 289(23): 3095–105. DOI: 10.1001/jama.289.23.3095
- Ghoneim M.M., O’Hara M.W. Depression and postoperative complications: an overview. BMC Surgery. 2016; 16(1). DOI: 10.1186/s12893-016-0120-y
- Marschall K.E., Hines R.L. Psychiatric disease/substance abuse/drug overdose. Stoelting’s: Anaesthesia and co-existing diseases. 7th ELSEVIER, 2017: 611–633.
- Huyse F.J., Touw D.J., Van Schijndel R.S., et al. Psychotropic Drugs and the Perioperative Period: A Proposal for a Guideline in Elective Surgery. Psychosomatics. 2006; 47(1): 8–22. DOI: 10.1176/appi.psy.47.1.8
- Lader M. Benzodiazepine harm: how can it be reduced? British Journal of Clinical Pharmacology. 2012; 77(2): 295–301. DOI: 10.1111/j.1365-2125.2012.04418.x
- Nigussie S., Belachew T., Wolancho W. Predictors of preoperative anxiety among surgical patients in Jimma University Specialized Teaching Hospital South Western Ethiopia. BMC Surgery. 2014; 14: 67. DOI: 10.1186/1471-2482-14-67
- Schädlich D., Friebel D., Schallner J., et al. Evaluation of haemostasis in children treated with valproic acid. Hamostaseologie. 2010; 30(Suppl. 1): S132–137.
- Teich M., Longin E., Dempfle C.-E., Konig S. Factor XIII Deficiency Associated with Valproate Treatment. Epilepsia. 2004; 45(2): 187–189. DOI: 10.1111/j.0013-9580.2004.28302.x
- Abdallah C. Considerations in perioperative assessment of valproic acid coagulopathy. Journal of Anaesthesiology Clinical Pharmacology. 2014; 30(1): 7–9. DOI: 10.4103/0970-9185.125685
- Hackam D.G., Mrkobrada M. Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis. Neurology. 2013; 79(18): 1862–1865. DOI: 10.1212/wnl.0b013e318271f848
- Mahdanian A.A., Rej S., Bacon S.L., et al. Serotonergic antidepressants and perioperative bleeding risk: a systematic review. Expert Opinion on Drug Safety. 2014; 13(6): 695–704. DOI: 10.1517/14740338.2014.908182
- Singh I., Achuthan S., Chakrabarti A., et al. Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis. Pharmacoepidemiology and Drug Safety. 2014; 24(3), 237–245. DOI: 10.1002/pds.3632
- Eckersley M.J., Sepehripour A.H., Casula R., et al. Do selective serotonin reuptake inhibitors increase the risk of bleeding or mortality following coronary artery bypass graft surgery? A meta-analysis of observational studies. Perfusion. 2018; 33(6): 415–422. DOI: 10.1177/0267659118765933
- Seitz D.P., Bell C.M., Gill S.S., et al. Risk of Perioperative Blood Transfusions and Postoperative Complications Associated With Serotonergic Antidepressants in Older Adults Undergoing Hip Fracture Surgery. Journal of Clinical Psychopharmacology. 2013; 33(6): 790–798. DOI: 10.1097/jcp.0b013e3182a58dce
- Van Walraven C., Mamdani M.M., Wells P.S., et al. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort. BMJ. 2001; 323(7314): 655–655. DOI: 10.1136/bmj.323.7314.655
- Meijer W.E.E., Heerdink E.R., Nolen W.A., et al. Association of Risk of Abnormal Bleeding With Degree of Serotonin Reuptake Inhibition by Antidepressants. Archives of Internal Medicine.2004; 164(21): 2367. DOI: 10.1001/archinte.164.21.2367
- Cheng Y.-L., Hu H.-Y., Lin X.-H., et al. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding. Medicine. 2015; 94(46): e2022. DOI: 10.1097/md.0000000000002022
- Shepshelovich D., Schechter A., Calvarysky B., et al. Medication-induced SIADH: distribution and characterization according to medication class. British Journal of Clinical Pharmacology. 2017; 83(8): 1801–1807. DOI: 10.1111/bcp.13256
- Lane R.M. SSRIs and hyponatraemia. Br J Clin Pract. 1997; 51(3): 144–146.
- Jacob S., Spinier S.A. Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults. Annals of Pharmacotherapy. 2006; 40(9): 1618–1622. DOI: 10.1345/aph.1g293
- Viramontes T.S., Truong H., Linnebur S.A. Antidepressant-Induced Hyponatremia in Older Adults. The Consultant Pharmacist. 2016; 31(3): 139–150. DOI: 10.4140/tcp.n.2016.139
- Gandhi S., Shariff S.Z., Al-Jaishi A., et al. Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults. American Journal of Kidney Diseases. 2016; 69(1): 87–96. DOI: 10.1053/j.ajkd.2016.08.020
- Goldman M.B. Psychotic Exacerbations and Enhanced Vasopressin Secretion in Schizophrenic Patients With Hyponatremia and Polydipsia. Archives of General Psychiatry. 1997; 54(5): DOI: 10.1001/archpsyc.1997.01830170069010
- Raja M. Lithium and Kidney, 60 Years Later. Current Drug Safety. 2011; 6(5): 291–303. DOI: 10.2174/157488611798918737
- Ibbeken C., Becker J., Baumgärtel M. Nephrologische Nebenwirkungen einer Langzeittherapie mit Lithium. DMW — Deutsche Medizinische Wochenschrift. 2012; 137(04): 143–148. DOI: 10.1055/s-0031-1298814
- Gahr M., Freudenmann R., Connemann B., et al. Nephrotoxizität und Langzeitbehandlung mit Lithium. Psychiatrische Praxis. 2013; 41(01): 15–22. DOI: 10.1055/s-0033-1349490
- Tredget J., Kirov A., Kirov G. Effects of chronic lithium treatment on renal function. Journal of Affective Disorders. 2010; 126(3): 436–440. DOI: 10.1016/j.jad.2010.04.018
- Sharma S., Joshi S., Chadda R.K. Therapeutic Drug Monitoring of Lithium in Patients With Bipolar Affective Disorder: Experiences From a Tertiary Care Hospital in India. American Journal of Therapeutics. 2009; 16(5): 393–397. DOI: 10.1097/mjt.0b013e31818a88da
- Köse G., Arhan E., Unal B., et al. Valproate-Associated Coagulopathies in Children During Short-Term Treatment. Journal of Child Neurology. 2009; 24(12): 1493–1498. DOI: 10.1177/0883073808331084
- Koenig S., Gerstner T., Keller A., et al. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study. Blood Coagulation & Fibrinolysis. 2008; 19(5): 375–382. DOI: 10.1097/mbc.0b013e3282f3f9ec
- Ugras M., Yakinci C. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate. Brain and Development. 2006; 28(9): 549–553. DOI: 10.1016/j.braindev.2006.03.009
- Verrotti A., Greco R., Matera V., et al. Platelet count and function in children receiving sodium valproate. Pediatric Neurology. 1999; 21(3): 611–614. DOI: 10.1016/s0887-8994(99)00060-0
- Kreuz W., Linde R., Funk M., et al. Valproate Therapy Induces von Willebrand Disease Type I. Epilepsia. 1992; 33(1): 178–184. DOI: 10.1111/j.1528-1157.1992.tb02303.x
- Delgado M.R., Riela A.R., Mills J., et al. Thrombocytopenia Secondary to High Valproate Levels in Children With Epilepsy. Journal of Child Neurology. 1994; 9(3): 311–314. DOI: 10.1177/088307389400900318
- Ko C.H., Kong C.K., Tse P.W. Valproic acid and thrombocytopenia: cross-sectional study. Hong Kong Med J. 2001; 7(1): 15–21.
- Trannel T.J., Ahmed I., Goebert D. Occurrence of Thrombocytopenia in Psychiatric Patients Taking Valproate. American Journal of Psychiatry. 2001; 158(1): 128–130. DOI: 10.1176/appi.ajp.158.1.128
- Vasudev K., Keown P., Gibb I., et al. Hematological Effects of Valproate in Psychiatric Patients. Journal of Clinical Psychopharmacology. 2010; 30(3), 282–285. DOI: 10.1097/jcp.0b013e3181db2684
- Bogetto F., Bellino S., Revello R.B., Patria L. Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors. CNS Drugs. 2002; 16(4): 273–283. DOI: 10.2165/00023210-200216040-00006
- Rosenbaum J.F., Fava M., Hoog S.L., et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry. 1998; 44(2): 77–87. DOI: 10.1016/s0006-3223(98)00126-7.
- Haddad P. Newer Antidepressants and the Discontinuation Syndrome. J Clin Psychiatry. 1997; 58(suppl. 7): 17–22.
- Mavandadi S., Ten Have T.R., Katz I.R., Durai U.N.B., et al. Effect of Depression Treatment on Depressive Symptoms in Older Adulthood: The Moderating Role of Pain. Journal of the American Geriatrics Society. 2007; 55(2): 202–211. DOI: 10.1111/j.1532-5415.2007.01042.x
- Perks A., Cheema S., Mohanraj R. Anaesthesia and epilepsy. British Journal of Anaesthesia. 2012; 108(4): 562–571. DOI: 10.1093/bja/aes027
- Chen M.-J., Zhang W.-J., Guo Z.-L., et al. Withdrawal reaction of carbamazepine after neurovascular decompression for trigeminal neuralgia: A preliminary study. Journal of the Neurological Sciences. 2014; 338(1–2): 43–45. DOI: 10.1016/j.jns.2013.12.013 постоянная ссылка на статью: sci-hub.si/10.1016/j.jns.2013.12.013
- Kudoh A., Kimura F., Murakawa T., et al. Perioperative management of patients on long-term administration of psychotropic drugs. Masui. 1993; 42(7): 1056–1064. Japanese. PMID:8350474
- Kudoh A., Katagai H., Takase H., Takazawa T. Endocrine Response to Surgical Stress and Postoperative Confusion in Depressed Patients with Alcohol Abuse. Neuropsychobiology. 2004; 50(3): 195–199. DOI: 10.1159/000079969
- Donnelly J.G., MacLeod A.D. Hypotension associated with clozapine after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 1999; 13(5): 597–599. DOI: 10.1016/s1053-0770(99)90016-2
- Desan P.H., Powsner S. Assessment and management of patients with psychiatric disorders. Critical Care Medicine. 2004; 32(Suppl.): S166–S173. DOI: 10.1097/01.ccm.0000120062.91105.51
- Kaye A.D., Hoover J.M., Ertner R.A., Sutker P.B. Behavioral and Psychiatric Disorders. In: Fliesher L.A., editor. Anesthesia and Uncommon diseases. 5th Philadelphia: Saunders Elsevier, 2006: 469–492.
- Bajwa S.S., Kaur J., Jindal R., et al. Psychiatric diseases: Need for an increased awareness among the anesthesiologists. Journal of Anaesthesiology Clinical Pharmacology. 2011; 27(4): 440. DOI: 10.4103/0970-9185.86572
- Krings-Ernst I., Ulrich S., Adli M. Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: A review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine. 2013; 51: 763–770. DOI: 10.5414/CP201898.
- Christodoulou G.N., Lykouras E.P. Abrupt lithium discontinuation in manic-depressive patients. Acta Psychiatrica Scandinavica. 1982; 65(5): 310–314. DOI: 10.1111/j.1600-0447.1982.tb00852.x
- De Cosmo G., Congedo E., Lai C., et al. Preoperative Psychologic and Demographic Predictors of Pain Perception and Tramadol Consumption Using Intravenous Patient-controlled Analgesia. The Clinical Journal of Pain. 2008; 24(5): 399–405. DOI: 10.1097/ajp.0b013e3181671a08
- Royse C., Remedios C., Royse A. High thoracic epidural analgesia reduces the risk of long-term depression in patients undergoing coronary artery bypass surgery. Ann Thorac Cardiovasc Surg. 2007; 13(1): 32–35.
- Royse C., Royse A., Soeding P., et al. Prospective randomized trial of high thoracic epidural analgesia for coronary artery bypass surgery. The Annals of Thoracic Surgery. 2003; 75(1): 93–100. DOI: 10.1016/s0003-4975(02)04074-2
- Singh M.K., Giles L.L., Nasrallah H.A. Pain Insensitivity in Schizophrenia: Trait or State Marker? Journal of Psychiatric Practice. 2006; 12(2): 90–102. DOI: 10.1097/00131746-200603000-00004
- БеккерР.А., Быков Ю.В. Проблематика проведения общей анестезии на фоне приема психофармакотерапии (Часть II). Портал Consilium Medicum: https://con-med.ru/upload/iblock/3c7/psi-for-site-bykov2.pdf Доступ к статье проверен 25.02.2020. [Becker R.A., Bykov S.E. Problems of conducting general anesthesia while taking psychopharmacotherapy (Part II). Portal Consilium Medicum: https://con-med.ru/upload/iblock/3c7/psi-for-site-bykov2.pdf (In Russ)]
- Patt R.B., Proper G., Reddy S. The neuroleptics as adjuvant analgesics. Journal of Pain and Symptom Management. 1994; 9(7): 446–453. DOI: 10.1016/0885-3924(94)90201-1
- Morgan G.E., Mikhail M.S., Murray M.J. Morgan: Clinical anaesthesiology. 4thed. USA: LANGE International edition. Anesthesia for patients with neurologic and psychiatric diseases. 2008: 647–61.
- Hill G.E., Wong K.C., Hodges M.R. Lithium Carbonate and Neuromuscular Blocking Agents. Anesthesiology. 1977; 46(2): 122–125. DOI: 10.1097/00000542-197702000-00008
- Fernandes S.C., Braga A.F., Braga F.S., et al. Influence of lithium on the neuromuscular blockade produced by atracurium and cisatracurium. Study on rat phrenic nerve-diaphragm preparations Rev. Bras. Anestesiol. 2007; 57(3): 289–230. DOI: 10.1590/S0034-70942007000300007.
- Graudins A., Vossler C., Wang R. Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy. The American Journal of Emergency Medicine. 1997; 15(5): 501–503. DOI: 10.1016/s0735-6757(97)90194-7
- Raviña T., Suarez M.L., Mendez-Castrillón J. Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. Int J Cardiol. 1998; 65(3): 311–313. DOI: 10.1016/s0167-5273(98)00095-3
- Erfurth A., Loew M., Dobmeier P., Wendler G. EKG-Veränderungen nach Paroxetin. Der Nervenarzt. 1998; 69(7): 629–631. DOI: 10.1007/s001150050321
- De la Torre B.R., Dreher J., Malevany I., et al. Serum Levels and Cardiovascular Effects of Tricyclic Antidepressants and Selective Serotonin Reuptake Inhibitors in Depressed Patients. Therapeutic Drug Monitoring. 2001; 23(4): 435–440. DOI: 10.1097/00007691-200108000-00019
- Pacher P., Kecskemeti V. Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns? Current Pharmaceutical Design. 2004; 10(20): 2463–2475. DOI: 10.2174/1381612043383872
- Khasawneh F.T., Shankar G.S. Minimizing Cardiovascular Adverse Effects of Atypical Antipsychotic Drugs in Patients with Schizophrenia. Cardiology Research and Practice. 2014; 2014: 1–8. DOI: 10.1155/2014/273060
- Takeguchi Y., Miyamoto Y., Sone T., Kato H. Severe hypotension during anesthesia in a patient on long-term antidepressant therapy. Masui. 2003; 52(3): 284–287.
- Smith F.A., Wittmann C.W., Stern T.A. Medical Complications of Psychiatric Treatment. Critical Care Clinics. 2008; 24(4): 635–656. DOI: 10.1016/j.ccc.2008.05.004
- Gugger J.J. Antipsychotic Pharmacotherapy and Orthostatic Hypotension. CNS Drugs. 2011; 25(8): 659–671. DOI: 10.2165/11591710-000000000-00000
- Using lithium safely. (1999). Drug and Therapeutics Bulletin. 1999; 37(3): 22–24. DOI: 10.1136/dtb.1999.37322
- Rosenqvist M., Bergfeldt L., Aili H., et al. Sinus node dysfunction during long-term lithium treatment. Heart. 1993; 70(4): 371–375. DOI: 10.1136/hrt.70.4.371
- Uchiyama Y., Nakao S., Asai T., Shingu K. A case of atropine-resistant bradycardia in a patient on long-term lithium medication. Masui. 2001; 50(11): 1229–1231.
- Montalescot G., Levy Y., Hatt P.Y. Serious sinus node dysfunction caused by therapeutic doses of lithium. International Journal of Cardiology. 1984; 5(1): 94–96. DOI: 10.1016/0167-5273(84)90064-0
- Mehta N., Vannozzi R. Lithium-induced electrocardiographic changes: A complete review. Clinical Cardiology. 2017; 40(12): 1363–1367. DOI: 10.1002/clc.22822
- Mehtonen O.-P., Aranko K., Mälkonen L., et al. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatrica Scandinavica. 1991; 84(1), 58–64. DOI: 10.1111/j.1600-0447.1991.tb01421.x
- Riccioni N., Roni P., Bartolomei C. Lithium-induced sinus node dysfunction. Acta Cardiol. 1983; 38(2): 133–138.
- Sprung J., Distel D., Grass J., et al. Cardiovascular collapse during anesthesia in a patient with preoperatively discontinued chronic MAO inhibitor therapy. Journal of Clinical Anesthesia. 1996; 8(8): 662–665. DOI: 10.1016/s0952-8180(96)00175-4
- Nakamura S., Takeda K., Nishiyama T., Hanaoka K. General anesthesia for a patient with Noonan’s syndrome and long-term antidepressant therapy. Masui. 2005; 54(8): 901–903.
- Takakura K., Nagaya M., Mori M., et al. Refractory Hypotension during Combined General and Epidural Anaesthesia in a Patient on Tricyclic Antidepressants. Anaesthesia and Intensive Care. 2006; 34(1): 111–114. DOI: 10.1177/0310057×0603400108
- Tran T.P., Panacek E.A., Rhee K.J., et al. Response to Dopamine vs Norepinephrine in Tricyclic Antidepressant-induced Hypotension. Academic Emergency Medicine. 1997; 4(9): 864–868. DOI: 10.1111/j.1553-2712.1997.tb03811.x
- Bovill J. Adverse Drug Interactions in Anesthesia. Journal of Clinical Anesthesia, 1997; 9(6): 3S–13S. DOI: 10.1016/s0952-8180(97)00119-0
- Janowsky E.C., Risch C., Janowsky D.S. Effects of Anesthesia on Patients Taking Psychotropic Drugs. Journal of Clinical Psychopharmacology. 1981; 1(1): 14–20. DOI: 10.1097/00004714-198101000-00004
- Kudoh A. Perioperative Management for Chronic Schizophrenic Patients. Anesthesia & Analgesia. 2005; 101(6): 1867–1872. DOI: 10.1213/01.ane.0000184123.67853.86
- Sawada N., Higashi K., Yanagi F., et al. Sudden onset of bronchospasm and persistent hypotension during spinal anesthesia in a patient on long-term psychotropic therapy. Masui. 1997; 46: 1225–1229.
- Dingemanse J., Guentert T., Gieschke R., Stabl M. Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemide. J Cardiovasc Pharmacol. 1996; 28(6): 856–861.
- Folk J.W., Kellner C.H., Beale M.D., et al. Anesthesia for Electroconvulsive Therapy: A Review. The Journal of ECT. 2000; 16(2): 157–170. DOI: 10.1097/00124509-200006000-00007
- Boakes A.J., Laurence D.R., Teoh P.C., et al. Interactions between Sympathomimetic Amines and Antidepressant Agents in Man. BMJ. 1973; 1(5849): 311–315. DOI: 10.1136/bmj.1.5849.311
- Huyse F.J., Touw D.J., Strack van Schijndel R.J., et al. Measures for patients taking psychotropic drugs who undergo elective surgery. [Article in Dutch] Ned Tijdschr Geneeskd. 2007; 151(6): 353–357.
- Desai N., Venkatesh C.R., Kumar S.S. QT prolongation and torsades de pointes with psychotropic agents. Indian J Psychiatry. 2015; 57(3): 305–308. DOI: 10.4103/0019-5545.166619.
- Glassman A.H., Bigger J.T. Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death. American Journal of Psychiatry. 2001; 158(11): 1774–1782. DOI: 10.1176/appi.ajp.158.11.1774
- Riley D.C., Schmeling W.T., Al Wathiqui M.H., et al. Prolongation of the QT interval by volatile anesthetics in chronically instrumented dog. Anesth. Analg. 1988; 67: 741–749.
- Lorentz M.N., Vianna B.S.B. Cardiac Dysrhythmias and Anesthesia. Brazilian Journal of Anesthesiology. 2011; 61(6): 798–813. DOI: 10.1016/s0034-7094(11)70090-3
- Kudoh A., Ishihara H., Matsuki A. Inhibition of the cortisol response to surgical stress in chronically depressed patients. Journal of Clinical Anesthesia. 2000; 12(5): 383–387. DOI: 10.1016/s0952-8180(00)00179-3
- БыковЮ.В., Беккер Р.А., Резников М.К. Депрессии и резистентность. М.: РИОР, 2013. [Bykov Yu.V., Bekker R.A., Reznikov M.K. Depressii i rezistentnost’. Prakticheskoye rukovodstvo. . Moscow: RIOR, 2013. (In Russ)]
- Doering L.V., Cross R., Vredevoe D., et al. Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Altern Ther Health Med. 2007; 13(3): 18–21.
- Bozic K.J., Lau E., Kurtz S., et al. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA. Clin Orthop Relat Res. 2012; 470(1): 130–137. DOI: 10.1007/s11999-011-2043-3.
- Chang S.M., Parney I.F., Mcdermott M., et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. Journal of Neurosurgery. 2003; 98(6), 1175–1181. DOI: 10.3171/jns.2003.98.6.1175
- Gordon R.J., Weinberg A.D., Pagani F.D., et al. Prospective, Multicenter Study of Ventricular Assist Device Infections. Circulation. 2013; 127(6), 691–702. DOI: 10.1161/circulationaha.112.128132
- Doering L.V., Moser D.K., Lemankiewicz W., et al. Depression, healing, and recovery from coronary artery bypass surgery. Am J Crit Care. 2005; 14(4): 316–324.
- Copeland L.A., Zeber J.E., Pugh M.J., et al. Postoperative Complications in the Seriously Mentally Ill. Annals of Surgery. 2008; 248(1): 31–38. DOI: 10.1097/sla.0b013e3181724f25
- Kazmierski J., Kowman M., Banach M., et al. Incidence and predictors of delirium after cardiac surgery: Results from The IPDACS Study. Journal of Psychosomatic Research. 2010; 69(2): 179–185. DOI: 10.1016/j.jpsychores.2010.02.009
- Kudoh A. Effect of epidural analgesia on postoperative paralytic ileus in chronic schizophrenia. Regional Anesthesia and Pain Medicine. 2001; 26(5): 456–460. DOI: 10.1053/rapm.2001.25062
- Vohra S.B. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Canadian Journal of Anaesthesia. 1994; 41(5): 420–422. DOI: 10.1007/bf03009865
- Kudoh A., Katagai H., Takazawa T. Anesthesia with ketamine, propofol, and fentanyl decreases the frequency of postoperative psychosis emergence and confusion in schizophrenic patients. Journal of Clinical Anesthesia. 2002; 14(2): 107–110. DOI: 10.1016/s0952-8180(01)00363-4
- Barann M., Stamer U.M., Lyutenska M., et al. Effects of opioids on human serotonin transporters. Naunyn-Schmiedeberg’s Archives of Pharmacology. 2014; 388(1): 43–49. DOI: 10.1007/s00210-014-1056-3
- Nelson E.M., Philbrick A.M. Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake Inhibitors. Annals of Pharmacotherapy. 2012; 46(12): 1712–1716. DOI: 10.1345/aph.1q748
- Fox M.A., Jensen C.L., Murphy D.L. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. The International Journal of Neuropsychopharmacology. 2009; 12(08): DOI: 10.1017/s146114570900011x
- Park S.H., Wackernah R.C., Stimmel G.L. Serotonin Syndrome. Journal of Pharmacy Practice. 2013; 27(1): 71–78. DOI: 10.1177/0897190013504957
- Сорокина В.В. Диагностика генетических вариантов CYP 2D6 и CYP 2C19 в аспекте применения наркотических анальгетиков. Кубанский научный медицинский вестник. 2009; 6(111): 151–154. [Sorokina V.V. Diagnostics genetic variant СYP 2D6 and CYP 2C19 in aspect of the using narcotic anaesthesiatizing. Kuban Scientific Medical Bulletin. 2009; 6(111): 151–154. (In Russ)]
- Abadie D., Rousseau V., Logerot S., et al. Serotonin Syndrome. Journal of Clinical Psychopharmacology. 2015; 35(4): 382–388. DOI: 10.1097/jcp.0000000000000344
- Kaye A.D., Liu H., Fox C., et al. Psychiatric and Behavioral Disorders. In: Fliesher L.A.,editor. Anesthesia and Uncommon diseases. 6th Philadelphia: Saunders Elsevier, 2012: 444–469.
- Kudoh A. Preoperative evaluation, preparation and prognosis in depressed patients. Masui. 2010; 59(9): 1116–1127.
- Brent J. Critical care toxicology: diagnosis and management of the critically poisoned patient. Elsevier Health Sciences, 2005: 485–488.
- Руководство по клинической анестезиологии. Пер. с англ. под ред. Б.Дж. Полларда; под общ. ред. Л.В. Колотилова, В.В. Мальцева. М.: МЕДпресс-информ, 2006. [Rukovodstvo po klinicheskoy anesteziologii. Pod red. B. Dzh. Pollarda; pod obshch. red. L.V. Kolotilova, V.V. Mal’tseva. Moscow: MEDpress-inform, 2006. (In Russ)]
- Ragheb M. The clinical significance of lithium-nonsteroidal anti-inflammatory drug interactions. J Clin Psychopharmacol. 1990; 10(5): 350–354.
- Ragheb M., Powell A.L. Lithium interaction with sulindac and naproxen. J Clin Psychopharmacol. 1986; 6(3): 150–154.
- Finley P.R., Warner M.D., Peabody C.A. Clinical Relevance of Drug Interactions with Lithium. Clinical Pharmacokinetics. 1995; 29(3): 172–191. DOI: 10.2165/00003088-199529030-00004
- Spina E., Santoro V., D’Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clinical Therapeutics. 2008; 30(7): 1206–1227. DOI: 10.1016/s0149-2918(08)80047-1
- Hemeryck A., Belpaire F. Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update. Current Drug Metabolism. 2002; 3(1): 13–37. DOI: 10.2174/1389200023338017
- Azaz-Livshits T., Danenberg H. Tachycardia, Orthostatic Hypotension and Profound Weakness Due to Concomitant Use of Fluoxetine and Nifedipine. Pharmacopsychiatry. 1997; 30(06): 274–275. DOI: 10.1055/s-2007-979508
- Owen J.R., Nemeroff C.B. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Depress Anxiety. 1998; 7(Suppl.1): 24–32.
- Armahizer M.J., Seybert A.L., Smithburger P.L., et al. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. Journal of Critical Care. 2013; 28(3): 243–249. DOI: 10.1016/j.jcrc.2012.10.014
- Egberts A.C.G., ter Borgh J., Brodie-Meijer C.C.E. Serotonin syndrome attributed to tramadol addition to paroxetine therapy. International Clinical Psychopharmacology. 1997; 12(3): DOI: 10.1097/00004850-199705000-00010
- Maeda S., Tomoyasu Y., Higuchi H., et al. Independent Predictors of Delay in Emergence From General Anesthesia. Anesthesia Progress. 2015; 62(1): 8–13. DOI: 10.2344/0003-3006-62.1.8
- Stahl S.M. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Application. Cambridge University Press. 4th 2013.
- Klotz U. Tramadol — the Impact of its Pharmacokinetic and Pharmacodynamic Properties on the Clinical Management of Pain. Arzneimittelforschung. 2011; 53(10): 681–687. DOI: 10.1055/s-0031-1299812
- Dawson J., Karalliedde L. Drug interactions and the clinical anaesthetist. European Journal of Anaesthesiology. 1998; 15(2): 172–189. DOI: 10.1111/j.0265-0215.1998.00269.x
- Hansen D., Syben R., Föhring U., Eyrich K. Kardiale Atropinwirkungen bei Patienten mit Antidepressiva-Medikation. AINS — Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie. 1994; 29(07): 413–416. DOI: 10.1055/s-2007-996772
- Martyr J.W., Orlikowski C.E.P. Epidural anaesthesia, ephedrine and phenylephrine in a patient taking moclobemide, a new monoamine oxidase inhibitor. Anaesthesia. 1996; 51(12): 1150–1152. DOI: 10.1111/j.1365-2044.1996.tb15054.x
- Cannizzaro E., Albisetti M., Wohlrab G., Schmugge M. Severe Bleeding Complications during Antiepileptic Treatment with Valproic Acid in Children. Neuropediatrics. 2007; 38(1): 42–45. DOI: 10.1055/s-2007-981448
- Israelian L.A., Lubnin A.Iu., Tseitlin A.M., et al. Hemostatic disorders caused by chronic use of valproic acid in neurosurgical patients. Thromboelastographic monitoring. Anesteziol Reanimatol. 2010; 4: 50–54.
- Acharya S., Bussel J.B. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000; 22(1): 62–65.
- Horlocker T.T., Wedel D.J., Rowlingson J.C., et al. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy. Regional Anesthesia and Pain Medicine. 2010; 35(1): 64–101. DOI: 10.1097/aap.0b013e3181c15c70
- Sandson N.B., Marcucci C., Bourke D.L., et al. An Interaction Between Aspirin and Valproate: The Relevance of Plasma Protein Displacement Drug-Drug Interactions. American Journal of Psychiatry. 2006; 163(11): 1891–1896. DOI: 10.1176/ajp.2006.163.11.1891
- Jiang H.-Y., Chen H.-Z., Hu X.-J., et al. Use of Selective Serotonin Reuptake Inhibitors and Risk of Upper Gastrointestinal Bleeding: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 2015; 13(1): 42–50.e3. DOI: 10.1016/j.cgh.2014.06.021
- Anglin R., Yuan Y., Moayyedi P., et al. Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 2014; 109(6): 811–819. DOI: 10.1038/ajg.2014.82
- Scheitz J.F., Turc G., Kujala L., et al. Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors. Stroke. 2017; 48(12): 3239–3244. DOI: 10.1161/strokeaha.117.018377
- Douros A., Ades M., Renoux C. Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review. CNS Drugs. 2018; 32(4): 321–334. DOI: 10.1007/s40263-018-0507-7
- Shaw A., Matthews E.E. Postoperative neuroleptic malignant syndrome. Anaesthesia. 1995; 50(3): 246–247. DOI: 10.1111/j.1365-2044.1995.tb04566.x
- So P.C. Neuroleptic malignant syndrome induced by droperidol. Hong Kong Med J. 2001; 7: 101–10
- Gillman P.K. Neuroleptic malignant syndrome: Mechanisms, interactions, and causality. Movement Disorders. 2010; 25(12): 1780–1790. DOI: 10.1002/mds.23220
- Bhalla T., Maxey D., Sawardekar A., Tobias J.D. Anesthetic management of a pediatric patient with neuroleptic malignant syndrome. Journal of Anesthesia. 2011; 26(2): 250–253. DOI: 10.1007/s00540-011-1269-2
- Федеральные клинические рекомендации по диагностике и лечению шизофрении (проект). Московский НИИ психиатрии. 2013. Обсуждение на сайте Российского Общества Психиатров — psychiatr.ru. [Federal’nye klinicheskie rekomendacii po diagnostike i lecheniyu shizofrenii (proekt). Moskovskij NII psihiatrii. 2013. Obsuzhdenie na sajte Rossijskogo Obshchestva Psihiatrov — psychiatr.ru. (In Russ)]
- Kishimoto S., Nakamura K., Arai T., et al. Postoperative neuroleptic malignant syndrome-like symptoms improved with intravenous diazepam: a case report. Journal of Anesthesia. 2013; 27(5): 768–770. DOI: 10.1007/s00540-013-1602-z
- Ramamoorthy K., Hawthorne P., Downey H. Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome. Journal of Anaesthesiology Clinical Pharmacology. 2011; 27(3): DOI: 10.4103/0970-9185.83687
- Remington G., Fervaha G., Foussias G., et al. Antipsychotic dosing: found in translation. Journal of Psychiatry & Neuroscience. 2014; 39(4): 223–231. DOI: 10.1503/jpn.130191
- Mailman R., Murthy V. Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity? Current Pharmaceutical Design. 2010; 16(5): 488–501. DOI: 10.2174/138161210790361461
- Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatric Disease and Treatment. 2016; 12: 931–939. DOI: 10.2147/ndt.s100908
- O’Keane V., Meaney A.M. Antipsychotic Drugs. Journal of Clinical Psychopharmacology. 2005; 25(1): 26–31. DOI: 10.1097/01.jcp.0000150223.31007.e0
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-ShareAlike» («Атрибуция — Некоммерческое использование — На тех же условиях») 4.0 Всемирная.
Copyright (c) 2021 ВЕСТНИК ИНТЕНСИВНОЙ ТЕРАПИИ имени А.И. САЛТАНОВА